Cradle Bio

Cradle Bio is an AI-driven protein design platform company based in Amsterdam. It provides a SaaS-like platform where biopharma and industrial biotechnology R&D teams can input their experimental data to generate and iteratively optimize protein sequences for multiple properties simultaneously. The company reports significant customer success, including projects that achieved a 50% experimental success rate for therapeutic peptides and improved vaccine thermostability 7x faster than traditional methods. Cradle operates as a B2B technology provider, partnering with major industry players like Novonesis to embed AI into their development workflows.

AI-powered software platform for generative and iterative protein design. It uses customer experimental data to train models that generate novel protein sequences optimized for multiple properties (e.g., stability, binding, expression) in a closed-loop design-make-test cycle.

Cradle competes in the AI for protein engineering space against pure-play biotech AI firms (e.g., Generate Biomedicines, Absci), large tech companies with biology initiatives (e.g., Google/Isomorphic Labs), and established molecular modeling software vendors adding AI capabilities. Its differentiation lies in a user-friendly platform focused on iterative optimization using customer data.